Abstract | INTRODUCTION: AREAS COVERED: Studies on several apoptosis-inducing agents that activate nuclear export of NR4A1, which subsequently forms a mitochondrial NR4A1-bcl-2 complex that induces the intrinsic pathway for apoptosis are discussed. Cytosporone B and related compounds that induce NR4A1-dependent apoptosis in cancer cells through both modulation of nuclear NR4A1 and nuclear export are discussed. A relatively new class of diindolylmethane analogs (C-DIMs) including 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane (DIM-C-pPhOCH(3)) (NR4A1 activator) and 1,1-bis(3'-indolyl)-1-(p-hydroxyphenyl)methane ( DIM-C-pPhOH) (NR4A1 deactivator) are discussed in more detail. These anticancer drugs (C-DIMs) act strictly through nuclear NR4A1 and induce apoptosis in cancer cells and tumors. EXPERT OPINION: It is clear that NR4A1 plays an important pro-oncogenic role in cancer cells and tumors, and there is increasing evidence that this receptor can be targeted by anticancer drugs that induce cell death via NR4A1-dependent and -independent pathways. Since many of these compounds exhibit relatively low toxicity, they represent an important class of mechanism-based anticancer drugs with excellent potential for clinical applications.
|
Authors | Syng-Ook Lee, Xi Li, Shaheen Khan, Stephen Safe |
Journal | Expert opinion on therapeutic targets
(Expert Opin Ther Targets)
Vol. 15
Issue 2
Pg. 195-206
(Feb 2011)
ISSN: 1744-7631 [Electronic] England |
PMID | 21204731
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
|
Chemical References |
- 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane
- Antineoplastic Agents
- Indoles
- Nuclear Receptor Subfamily 4, Group A, Member 1
- Phenols
- Phenylacetates
- cytosporone B
|
Topics |
- Active Transport, Cell Nucleus
(drug effects)
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Nucleus
(metabolism)
- Humans
- Indoles
(pharmacology)
- Mice
- Molecular Targeted Therapy
- Neoplasms
(drug therapy, metabolism, pathology)
- Nuclear Receptor Subfamily 4, Group A, Member 1
(antagonists & inhibitors, genetics, metabolism)
- Phenols
(pharmacology)
- Phenylacetates
(metabolism, pharmacology)
- RNA Interference
|